Concord Medical Co Ltd 6518

Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specialized in cancer treatment, research, education and prevention in China, today announced that it filed its annual report on Form 20-F for the fiscal year ended December 31, 2025 (the "Annual Report") with the U.S. Securities and Exchange Commission ("SEC"). An electronic copy of the Annual Report can be accessed on Concord Medical's investor relations website at http://ir.ccm.cn